Is Antiphospholipid / Hughes Syndrome hereditary?

Antiphospholipid syndrome (APS), also known as Hughes syndrome, is not considered a strictly hereditary or single-gene genetic disorder, but rather a complex, multifactorial autoimmune condition. While there is no direct Mendelian inheritance pattern, family studies suggest a genetic predisposition that, when combined with environmental triggers, may increase the risk of developing Hughes syndrome within certain families.

Is Antiphospholipid / Hughes Syndrome hereditary?

In clinical genetics, we distinguish between a "genetic" condition (caused by a DNA mutation) and a "hereditary" condition (passed directly from parent to child via a predictable pattern). Antiphospholipid syndrome does not follow a simple autosomal dominant or recessive inheritance pattern. Instead, it is classified as a multifactorial autoimmune disorder. This means that an individual may inherit a constellation of susceptibility genes that regulate the immune system, but the actual development of Hughes syndrome requires additional environmental factors, such as infections or other triggers, to manifest the clinical symptoms of blood clotting and pregnancy complications.

What is the risk to family members of those with Hughes syndrome?

Because Antiphospholipid syndrome is not caused by a single gene mutation, we cannot provide a specific percentage risk for children of an affected parent. While first-degree relatives of patients with Hughes syndrome may have a higher prevalence of autoantibodies compared to the general population, the vast majority of these relatives will never develop the clinical disease itself. There is no evidence of de novo (spontaneous) mutations causing this condition, as it is not a primary genetic syndrome.

Is genetic testing available for Antiphospholipid / Hughes Syndrome?

Currently, there is no standardized "genetic test" for Antiphospholipid syndrome. Clinical diagnosis relies on the presence of specific clinical criteria (such as vascular thrombosis or pregnancy morbidity) and laboratory confirmation of antiphospholipid antibodies. Genetic counseling is generally not focused on identifying a causative mutation but rather on the following clinical management goals:

• Assessing personal and family history of autoimmune disorders.


• Providing guidance for high-risk pregnancies, as Hughes syndrome can complicate fetal development.


• Educating family members on the symptoms of thrombosis to ensure early medical intervention.


• Discussing the multifactorial nature of the disease to reduce anxiety regarding "passing on" the condition.

What is the role of genetic counseling in pregnancy planning?

For patients with Antiphospholipid syndrome who are planning a pregnancy, genetic counseling is often integrated into high-risk obstetric care. A counselor can help map out the family history to identify if there is a broader "autoimmune cluster" in the family, which may influence monitoring protocols. While prenatal diagnosis (such as amniocentesis or CVS) is not indicated for Hughes syndrome because it is not a chromosomal or single-gene disorder, close monitoring by a rheumatologist and a maternal-fetal medicine specialist is essential to manage the risks of clotting and placental insufficiency.

Next steps

• Consult a rheumatologist or hematologist to confirm your diagnosis through established clinical criteria (the Sapporo or Sydney criteria).


• Connect with the DiseaseMaps.org community of 451 members to share experiences with others living with Antiphospholipid syndrome.


• If you are pregnant or planning a pregnancy, request a referral to a maternal-fetal medicine specialist familiar with the management of Hughes syndrome.


• Keep a detailed family health history to share with your primary care provider to help them monitor your first-degree relatives for autoimmune symptoms.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Antiphospholipid syndrome.


• Orphanet: Antiphospholipid syndrome (ORPHA:80).


• Hughes Syndrome Foundation: Clinical research and patient resources.


• OMIM (Online Mendelian Inheritance in Man): Entry #107740 (Antiphospholipid syndrome).